• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CRISPR/Cas9介导的基因组编辑通过可变剪接或外显子缺失诱导外显子跳跃。

CRISPR/Cas9-mediated genome editing induces exon skipping by alternative splicing or exon deletion.

作者信息

Mou Haiwei, Smith Jordan L, Peng Lingtao, Yin Hao, Moore Jill, Zhang Xiao-Ou, Song Chun-Qing, Sheel Ankur, Wu Qiongqiong, Ozata Deniz M, Li Yingxiang, Anderson Daniel G, Emerson Charles P, Sontheimer Erik J, Moore Melissa J, Weng Zhiping, Xue Wen

机构信息

RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, 01605, USA.

David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02142, USA.

出版信息

Genome Biol. 2017 Jun 14;18(1):108. doi: 10.1186/s13059-017-1237-8.

DOI:10.1186/s13059-017-1237-8
PMID:28615073
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5470253/
Abstract

CRISPR is widely used to disrupt gene function by inducing small insertions and deletions. Here, we show that some single-guide RNAs (sgRNAs) can induce exon skipping or large genomic deletions that delete exons. For example, CRISPR-mediated editing of β-catenin exon 3, which encodes an autoinhibitory domain, induces partial skipping of the in-frame exon and nuclear accumulation of β-catenin. A single sgRNA can induce small insertions or deletions that partially alter splicing or unexpected larger deletions that remove exons. Exon skipping adds to the unexpected outcomes that must be accounted for, and perhaps taken advantage of, in CRISPR experiments.

摘要

CRISPR被广泛用于通过诱导小的插入和缺失来破坏基因功能。在这里,我们表明一些单向导RNA(sgRNA)可以诱导外显子跳跃或删除外显子的大基因组缺失。例如,对编码自抑制结构域的β-连环蛋白外显子3进行CRISPR介导的编辑,会诱导该读码框内的外显子部分跳跃,并导致β-连环蛋白在细胞核中积累。单个sgRNA可以诱导小的插入或缺失,从而部分改变剪接,或者诱导意外的更大缺失,从而删除外显子。外显子跳跃增加了CRISPR实验中必须考虑甚至可能加以利用的意外结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/185a/5470253/171efe09d672/13059_2017_1237_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/185a/5470253/b1c5dff2fa33/13059_2017_1237_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/185a/5470253/d43604e2828d/13059_2017_1237_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/185a/5470253/2117a6eea737/13059_2017_1237_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/185a/5470253/171efe09d672/13059_2017_1237_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/185a/5470253/b1c5dff2fa33/13059_2017_1237_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/185a/5470253/d43604e2828d/13059_2017_1237_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/185a/5470253/2117a6eea737/13059_2017_1237_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/185a/5470253/171efe09d672/13059_2017_1237_Fig4_HTML.jpg

相似文献

1
CRISPR/Cas9-mediated genome editing induces exon skipping by alternative splicing or exon deletion.CRISPR/Cas9介导的基因组编辑通过可变剪接或外显子缺失诱导外显子跳跃。
Genome Biol. 2017 Jun 14;18(1):108. doi: 10.1186/s13059-017-1237-8.
2
CRISPR-Cas9 gene editing causes alternative splicing of the targeting mRNA.CRISPR-Cas9 基因编辑导致靶向 mRNA 的可变剪接。
Biochem Biophys Res Commun. 2020 Jul 12;528(1):54-61. doi: 10.1016/j.bbrc.2020.04.145. Epub 2020 May 24.
3
CRISPR/Cas9-mediated genome editing induces exon skipping by complete or stochastic altering splicing in the migratory locust.CRISPR/Cas9 介导的基因组编辑通过完全或随机改变飞行蝗中的剪接而诱导外显子跳跃。
BMC Biotechnol. 2018 Sep 25;18(1):60. doi: 10.1186/s12896-018-0465-7.
4
Unexpected extra exon skipping in the DYSF gene during restoring the reading frame by CRISPR/Cas9.CRISPR/Cas9 介导的读框修复过程中 DYSF 基因出现意料外的外显子跳跃。
Biosystems. 2024 Jan;235:105072. doi: 10.1016/j.biosystems.2023.105072. Epub 2023 Nov 7.
5
Machine learning based CRISPR gRNA design for therapeutic exon skipping.基于机器学习的用于治疗性外显子跳跃的CRISPR gRNA设计
PLoS Comput Biol. 2021 Jan 8;17(1):e1008605. doi: 10.1371/journal.pcbi.1008605. eCollection 2021 Jan.
6
Understanding and repurposing CRISPR-mediated alternative splicing.理解和重新利用 CRISPR 介导的可变剪接。
Genome Biol. 2018 Nov 6;19(1):184. doi: 10.1186/s13059-018-1565-3.
7
Restoration of Dystrophin Protein Expression by Exon Skipping Utilizing CRISPR-Cas9 in Myoblasts Derived from DMD Patient iPS Cells.利用CRISPR-Cas9通过外显子跳跃恢复来自杜氏肌营养不良症(DMD)患者诱导多能干细胞(iPS细胞)的成肌细胞中肌营养不良蛋白的表达。
Methods Mol Biol. 2018;1828:191-217. doi: 10.1007/978-1-4939-8651-4_12.
8
Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skipping.用于包装 CRISPR-Cas9 蛋白和 sgRNA 的细胞外纳米囊泡,以诱导治疗性外显子跳跃。
Nat Commun. 2020 Mar 13;11(1):1334. doi: 10.1038/s41467-020-14957-y.
9
Correction of Three Prominent Mutations in Mouse and Human Models of Duchenne Muscular Dystrophy by Single-Cut Genome Editing.通过单切基因组编辑纠正杜氏肌营养不良症小鼠和人类模型中的三个突出突变。
Mol Ther. 2020 Sep 2;28(9):2044-2055. doi: 10.1016/j.ymthe.2020.05.024. Epub 2020 May 30.
10
SliceIt: A genome-wide resource and visualization tool to design CRISPR/Cas9 screens for editing protein-RNA interaction sites in the human genome.SliceIt:一个全基因组资源和可视化工具,用于设计 CRISPR/Cas9 筛选,以编辑人类基因组中蛋白质-RNA 相互作用位点。
Methods. 2020 Jun 1;178:104-113. doi: 10.1016/j.ymeth.2019.09.004. Epub 2019 Sep 5.

引用本文的文献

1
Generation of NOD SCID mice with near-complete deletions of Il2rg and Prkdc for human cancer and HSC engraftment.用于人类癌症和造血干细胞植入的Il2rg和Prkdc近乎完全缺失的NOD SCID小鼠的生成。
Transgenic Res. 2025 Jul 11;34(1):35. doi: 10.1007/s11248-025-00454-9.
2
CRISPR GENome and epigenome engineering improves loss-of-function genetic-screening approaches.CRISPR基因组和表观基因组工程改进了功能丧失型基因筛选方法。
Cell Rep Methods. 2025 Jun 16;5(6):101078. doi: 10.1016/j.crmeth.2025.101078. Epub 2025 Jun 10.
3
CRISPR-directed exon skipping; friend or foe (opportunity or warning sign)?

本文引用的文献

1
Genetic disruption of oncogenic Kras sensitizes lung cancer cells to Fas receptor-mediated apoptosis.致癌性 Kras 的基因敲除使肺癌细胞对 Fas 受体介导的细胞凋亡敏感。
Proc Natl Acad Sci U S A. 2017 Apr 4;114(14):3648-3653. doi: 10.1073/pnas.1620861114. Epub 2017 Mar 20.
2
Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy.肌肉特异性 CRISPR/Cas9 肌营养不良蛋白基因编辑改善杜氏肌营养不良症小鼠模型的病理生理学。
Nat Commun. 2017 Feb 14;8:14454. doi: 10.1038/ncomms14454.
3
Random Splicing of Several Exons Caused by a Single Base Change in the Target Exon of CRISPR/Cas9 Mediated Gene Knockout.
CRISPR 引导的外显子跳跃:是福是祸(机遇还是警示信号)?
Mol Ther Nucleic Acids. 2025 Apr 29;36(2):102539. doi: 10.1016/j.omtn.2025.102539. eCollection 2025 Jun 10.
4
Design of lipid nanoparticle (LNP) containing genetic material CRISPR/Cas9 for familial hypercholesterolemia.用于家族性高胆固醇血症的含基因材料CRISPR/Cas9的脂质纳米颗粒(LNP)设计
Narra J. 2025 Apr;5(1):e2217. doi: 10.52225/narra.v5i1.2217. Epub 2025 Apr 15.
5
Analysis of Exon Skipping Applicability for Dysferlinopathies.dysferlinopathy外显子跳跃适用性分析
Cells. 2025 Jan 24;14(3):177. doi: 10.3390/cells14030177.
6
Neutrophil CRACR2A Promotes Neutrophil Recruitment in Sterile Inflammation and Ischemic Stroke.中性粒细胞CRACR2A在无菌性炎症和缺血性中风中促进中性粒细胞募集。
Circulation. 2025 Mar 11;151(10):696-715. doi: 10.1161/CIRCULATIONAHA.124.070487. Epub 2024 Nov 27.
7
Strategies for programmable manipulation of alternative splicing.可编程剪接的策略。
Curr Opin Genet Dev. 2024 Dec;89:102272. doi: 10.1016/j.gde.2024.102272. Epub 2024 Oct 29.
8
AAV vector-derived elements integrate into Cas9-generated double-strand breaks and disrupt gene transcription.AAV 载体衍生元件整合到 Cas9 产生的双链断裂处,并破坏基因转录。
Mol Ther. 2024 Nov 6;32(11):4122-4137. doi: 10.1016/j.ymthe.2024.09.032. Epub 2024 Oct 4.
9
Impact of essential genes on the success of genome editing experiments generating 3313 new genetically engineered mouse lines.对产生 3313 条新基因工程小鼠品系的基因组编辑实验的关键基因的影响。
Sci Rep. 2024 Sep 30;14(1):22626. doi: 10.1038/s41598-024-72418-8.
10
A CRISPR-dCas13 RNA-editing tool to study alternative splicing.一种用于研究可变剪接的 CRISPR-dCas13 RNA 编辑工具。
Nucleic Acids Res. 2024 Oct 28;52(19):11926-11939. doi: 10.1093/nar/gkae682.
CRISPR/Cas9介导的基因敲除中,目标外显子的单个碱基变化导致多个外显子的随机剪接。
Cells. 2016 Dec 14;5(4):45. doi: 10.3390/cells5040045.
4
Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.全基因组CRISPR筛选鉴定出丝裂原活化蛋白激酶的调节因子可作为小鼠肝脏肿瘤的抑制因子。
Gastroenterology. 2017 Apr;152(5):1161-1173.e1. doi: 10.1053/j.gastro.2016.12.002. Epub 2016 Dec 10.
5
Gene therapies that restore dystrophin expression for the treatment of Duchenne muscular dystrophy.通过恢复抗肌萎缩蛋白表达来治疗杜氏肌营养不良症的基因疗法。
Hum Genet. 2016 Sep;135(9):1029-40. doi: 10.1007/s00439-016-1725-z. Epub 2016 Aug 20.
6
Leveraging Rules of Nonsense-Mediated mRNA Decay for Genome Engineering and Personalized Medicine.利用无义介导的mRNA衰变规则进行基因组工程和个性化医疗。
Cell. 2016 Jun 2;165(6):1319-1322. doi: 10.1016/j.cell.2016.05.053.
7
Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo.通过在体内联合病毒和非病毒递送CRISPR系统组件进行治疗性基因组编辑。
Nat Biotechnol. 2016 Mar;34(3):328-33. doi: 10.1038/nbt.3471. Epub 2016 Feb 1.
8
In vivo gene editing in dystrophic mouse muscle and muscle stem cells.营养不良小鼠肌肉和肌肉干细胞中的体内基因编辑。
Science. 2016 Jan 22;351(6271):407-411. doi: 10.1126/science.aad5177. Epub 2015 Dec 31.
9
In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy.体内基因组编辑改善了杜兴氏肌肉营养不良小鼠模型的肌肉功能。
Science. 2016 Jan 22;351(6271):403-7. doi: 10.1126/science.aad5143. Epub 2015 Dec 31.
10
Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy.产后基因编辑可部分恢复肌营养不良小鼠模型中的肌营养不良蛋白表达。
Science. 2016 Jan 22;351(6271):400-3. doi: 10.1126/science.aad5725. Epub 2015 Dec 31.